Jilin Aodong Pharmaceutical Group Co., Ltd.
000623
Rang in aandelen
#4951
Jilin Aodong Pharmaceutical Group Co., Ltd. operates in China, principally... Jilin Aodong Pharmaceutical Group Co., Ltd. operates in China, principally focusing on the production and distribution of a broad spectrum of pharmaceutical goods. Its product line encompasses various drug forms like oral liquids, injections, capsules, granules, pills, and tablets, as well as traditional Chinese herbal medicines, powders, syrups, and spirits. The company also produces specialized medicinal products, including enzymes, biochemical drugs, and plant-based chemical medicines. In addition to its core pharmaceutical activities, Jilin Aodong diversifies its operations across several other sectors. These include highway construction and toll management, animal husbandry, the creation of specialty chemicals, and the provision of heat and water. The company further engages in the wholesale, retail, and distribution of medicines, packaging design and printing, the manufacturing of medicinal packaging materials, and delivers information consulting and advertising design solutions. Founded in 1957, its corporate headquarters are situated in Dunhua, China.
Aandeelprijs
$2.47
Marktkapitalisatie
$2.95B
Verandering (1 dag)
0.00%
Verandering (1 jaar)
-14.68%
Land
CN
Handel Jilin Aodong Pharmaceutical Group Co., Ltd. (000623)
Categorie
Healthcare
P/S-ratio voor Jilin Aodong Pharmaceutical Group Co., Ltd. (000623)
P/S-ratio op October 2026 TTM: 9.16
Volgens de meest recente financiële rapporten en aandelenkoers van Jilin Aodong Pharmaceutical Group Co., Ltd. is de huidige P/S-ratio (TTM) 9.16. Eind 2023 had het bedrijf een P/S-ratio van 4.95.
P/S-ratiohistoriek voor Jilin Aodong Pharmaceutical Group Co., Ltd. van 2000 tot 2026
P/S-ratio aan het einde van elk jaar
| Jaar | P/S-ratio | Wijzigen |
|---|---|---|
| 2026 (TTM) | 9.16 | 17.55% |
| 2024 | 7.79 | 57.42% |
| 2023 | 4.95 | -16.58% |
| 2022 | 5.93 | -35.08% |
| 2021 | 9.14 | 7.82% |
| 2020 | 8.47 | 36.12% |
| 2019 | 6.22 | 23.83% |
| 2018 | 5.03 | -43.06% |
| 2017 | 8.83 | -11.71% |
| 2016 | 10.00 | -15.67% |
| 2015 | 11.86 | -14.55% |
| 2014 | 13.88 | 70.41% |
| 2013 | 8.14 | -22.90% |
| 2012 | 10.56 | -13.66% |
| 2011 | 12.23 | -30.20% |
| 2010 | 17.52 | -36.38% |
| 2009 | 27.55 | 138.21% |
| 2008 | 11.56 | -74.15% |
| 2007 | 44.73 | 263.35% |
| 2006 | 12.31 | 492.21% |
| 2005 | 2.08 | 6.97% |
| 2004 | 1.94 | -2.21% |
| 2003 | 1.99 | -38.79% |
| 2002 | 3.25 | -45.50% |
| 2001 | 5.96 | -42.80% |
| 2000 | 10.41 | 0.00% |
P/S-ratio voor vergelijkbare bedrijven of concurrenten
| Bedrijf | P/S-ratio | Verschil in P/S-ratio | Land |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| 7.06 | -22.92% |
IN
|
